Open Access
Participation of sphingolipids in the pathogenesis of atherosclerosis
Тип публикации: Journal Article
Дата публикации: 2019-08-08
Включен в RSCI
scimago Q3
wos Q4
БС3
SJR: 0.250
CiteScore: 1.8
Impact factor: 0.5
ISSN: 00229040, 24125660
PubMed ID:
31397233
Cardiology and Cardiovascular Medicine
Краткое описание
Lipid metabolism disorders are the most significant risk factor of development of cardiovascular diseases (CVD). In the process of diagnosing ischemic heart disease and other cardiovascular pathologies, levels of total cholesterol, low- and high- density lipoprotein cholesterol, triglycerides are determined. However, in recent years, close attention has been paid to the intersection of the metabolic pathways of the biosynthesis of cholesterol and sphingolipids. Sphingolipids - a group of lipids, which include a molecule of aliphatic alcohol sphingosine. This group includes sphingomyelins, cerebrosides, gangliosides and ceramides, sphingosines and sphingosine-1-phosphate (S-1-P). Ceramides and sphingosines have pro-apoptotic properties, and S-1-P protects cells from apoptosis. Particular attention as inducer CVD attracts ceramide. It has been established that aggregated lipoproteins isolated from atherosclerotic zones are enriched with ceramides. The level of ceramide and sphingosine increases with ischemia/reperfusion of the heart, in the infarction zone and in the blood, and also in hypertensive disease. S-1-P has a pronounced cardioprotective properties. Its content sharply decreases with ischemia and myocardial infarction. S-1-P performs a special function in the structure of high-density lipoproteins (HDL), being one of the main lipid components of these lipoproteins, which determines their multiple functions. Recently, work has been underway to create drugs that can correct the metabolism of S-1-P. The most successful drugs are those that use the S-1-P receptor as a target, since all of its actions are carried out through receptors. Increasing ceramide and sphingosine and reducing blood plasma level of S-1-P can be an important factor in the development of atherosclerosis. It is proposed to use the determination of the level of sphingolipids in blood plasma for early diagnosis of cardiac ischemia and in arterial hypertension. Chromatography-mass spectrometry has been suggested as the main method for testing these lipids.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
|
|
|
Journal of Analytical Chemistry
1 публикация, 16.67%
|
|
|
IUBMB Life
1 публикация, 16.67%
|
|
|
Russian Journal of Developmental Biology
1 публикация, 16.67%
|
|
|
Obesity and Metabolism
1 публикация, 16.67%
|
|
|
Perm Medical Journal
1 публикация, 16.67%
|
|
|
Cardiosomatics
1 публикация, 16.67%
|
|
|
1
|
Издатели
|
1
2
|
|
|
Pleiades Publishing
2 публикации, 33.33%
|
|
|
Eco-Vector LLC
2 публикации, 33.33%
|
|
|
Wiley
1 публикация, 16.67%
|
|
|
Endocrinology Research Centre
1 публикация, 16.67%
|
|
|
1
2
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
6
Всего цитирований:
6
Цитирований c 2024:
0
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Alessenko A. et al. Participation of sphingolipids in the pathogenesis of atherosclerosis // Kardiologiya. 2019. Vol. 59. No. 8. pp. 77-87.
ГОСТ со всеми авторами (до 50)
Скопировать
Alessenko A., Zateyshchikov D. A., Lebedev A. Т., Kurochkin I. N. Participation of sphingolipids in the pathogenesis of atherosclerosis // Kardiologiya. 2019. Vol. 59. No. 8. pp. 77-87.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.18087/cardio.2019.8.10270
UR - https://doi.org/10.18087/cardio.2019.8.10270
TI - Participation of sphingolipids in the pathogenesis of atherosclerosis
T2 - Kardiologiya
AU - Alessenko, A.V.
AU - Zateyshchikov, D A
AU - Lebedev, A Т
AU - Kurochkin, I N
PY - 2019
DA - 2019/08/08
PB - APO Society of Specialists in Heart Failure
SP - 77-87
IS - 8
VL - 59
PMID - 31397233
SN - 0022-9040
SN - 2412-5660
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2019_Alessenko,
author = {A.V. Alessenko and D A Zateyshchikov and A Т Lebedev and I N Kurochkin},
title = {Participation of sphingolipids in the pathogenesis of atherosclerosis},
journal = {Kardiologiya},
year = {2019},
volume = {59},
publisher = {APO Society of Specialists in Heart Failure},
month = {aug},
url = {https://doi.org/10.18087/cardio.2019.8.10270},
number = {8},
pages = {77--87},
doi = {10.18087/cardio.2019.8.10270}
}
Цитировать
MLA
Скопировать
Alessenko, A.V., et al. “Participation of sphingolipids in the pathogenesis of atherosclerosis.” Kardiologiya, vol. 59, no. 8, Aug. 2019, pp. 77-87. https://doi.org/10.18087/cardio.2019.8.10270.
Профили